Please assess the completion status of the following clinical trial:

Trial Title: The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of schizophrenia~* No relapse and hospitalization~* Ambulant psychiatric treatment~Exclusion Criteria:~* Other psychotic disorders~* Relapse and hospitalization~* Substance abuse

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Therapy Group A (Type: EXPERIMENTAL): Therapy Group A Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~5 individuals with schizophrenia
- Therapy Group B (Type: EXPERIMENTAL): Therapy Group B Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~2 individuals with schizophrenia
- Therapy Group C (Type: EXPERIMENTAL): Therapy Group C Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~8
- Therapy Group D (Type: EXPERIMENTAL): Therapy Group D Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~8
- Therapy Group E (Type: EXPERIMENTAL): Therapy Group E Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~3
- Therapy Group F (Type: EXPERIMENTAL): Therapy Group F Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~3
- Therapy Group G (Type: EXPERIMENTAL): Therapy Group G Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented 3
- Therapy Group H (Type: EXPERIMENTAL): Therapy Group H Intervention: Pharmacotherapy in combination with the Integrated Psychological Therapy and Metacognitive Training will be implemented.~3

Based on this trial design, predict the completion outcome and termination type (if applicable).